U.S. factory production drops for first time in three months
American manufacturing is barely expanding as global demand and domestic business investment remain uninspiring.
Bloomberg News
Articles
Lilly to sell insulin at 40 percent discount to cash-paying patients
Eli Lilly and Co. will bypass insurance companies to offer a discount on its best-selling insulin products for patients who lack health coverage or have high deductibles that require them to pay the full cost of some medications.
Anthem-Cigna merger goes to judge for ruling that could end deal
U.S. District Judge Amy Berman Jackson in Washington, D.C., will issue a decision on whether the combination of the companies risks higher costs for large employers around the country and should be blocked.
NFL’s brain-damage deal survives as top court spurns appeals
U.S. Supreme Court justices, without comment, left intact a federal appeals court ruling that the agreement, while imperfect, was a fair resolution of claims filed on behalf of more than 20,000 retired NFL players.
Starbucks’ plan to win lunch crowd may be tough task for new CEO
Starbucks Corp. wants to persuade its coffee-loving customers to come back for lunch, after stumbling several times in previous attempts to expand its food offerings.
Pharma stocks slide after Trump’s vow to control drug costs
President-elect Donald Trump promised to drive down the cost of medicines, defying investors who saw a boon in his election last month and injecting himself again into a contentious economic debate.
Lilly threatens Sanofi’s dominance in insulin with knockoff drug
In a few days, a new type of knockoff medicine will upend a $10 billion diabetes-drug market and exacerbate a brutal price war between some of its biggest players.
Health insurers willing to give up key Obamacare provision
U.S. health insurers signaled Tuesday that they’re willing to give up a cornerstone provision of Obamacare that requires all Americans to have insurance.
Trump’s ‘retribution’ tax stirs questions, GOP resistance
Donald Trump’s threats to use taxes as “retribution” against U.S. companies that move jobs overseas are legally dubious, tax specialists say—and they’re prompting resistance from some Republican leaders who fear a coming era of economic protectionism.
Carrier, fresh off Trump talks, increases prices due to higher costs
The United Technologies Corp. division that includes brands such as Carrier and Bryant will raise the amount it charges for residential and commercial HVAC equipment by as much as 5 percent, according to a company statement.
Lilly competitor to cap price increases as drug costs face more scrutiny
With drug companies under fire, the world’s largest insulin maker plans to limit price increases and introducing a model that ties the cost of medicines to the results they deliver.
Trump claims victory at Carrier, but many manufacturing battles remain
Union workers and economists say pressuring individual factory owners won’t save U.S. manufacturing jobs lost to economic forces that are beyond the control of companies or the president.
Manufacturing in U.S. expands at best pace in five months
Eleven of 18 industries surveyed by the Institute for Supply Management posted growth in November, including petroleum, paper, plastics and computers and electronics.
Anthem’s Cigna takeover could draw $3B Blue Cross fine, exec testifies
Twenty-three percent of Cigna’s domestic revenue would need to be rebranded to comply with rules of the Blue Cross Blue Shield association, said Anthem executive Steve Schlegel under questioning Wednesday by a Justice Department lawyer.
Treasury pick Mnuchin predicts tax cuts to double U.S. growth
U.S. Treasury Secretary-nominee Steven Mnuchin outlined an economic agenda aimed at almost doubling the growth rate of the current expansion, saying he will boost jobs by making tax reform his overriding priority.
Anthem-Cigna CEOs’ deep clash exposed in unsealed testimony
The rift between merging health insurance companies Cigna Corp. and Anthem Inc. came further into public view Tuesday as transcripts of testimony from both chief executives were unsealed during a U.S. antitrust trial
Trump vows total exit from business while offering scant details
President-elect Donald Trump said Wednesday he plans to leave his business “in total” to focus on the White House and will discuss the matter at a news conference Dec. 15 in New York with his children, some of whom are business associates.
Anthem experts testify Cigna merger won’t hurt competition
Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition.
Trump picks Pence ally Verma for cabinet position
President-elect Donald Trump on Tuesday said he’ll nominate Seema Verma, founder of Indianapolis-based SVC Inc. and architect of the Healthy Indiana Plan, as his pick for administrator of the Centers for Medicare and Medicaid Services.
Economist testifies Anthem-Cigna deal a risk to competition
Anthem Inc.’s proposed $48 billion merger with Cigna Corp. could give the insurer the power to raise prices for employers across the country, according to a witness in the U.S. government’s lawsuit to block the deal.